Eagle Pharmaceuticals Inc.

Eagle Pharmaceuticals Inc. is focused on clinical research in severe community-acquired bacterial pneumonia (SCABP), with attention to treatment options for serious bacterial lung infection requiring hospital-based care.

• Severe bacterial pneumonia
• Community-acquired respiratory infection
• Clinical recovery

The sponsor’s research interest in this area centers on improving outcomes in patients with advanced respiratory infection and evaluating treatment approaches alongside standard of care.